Cognition Therapeutics (CGTX) Institutional Ownership $0.58 -0.03 (-4.33%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.60 +0.02 (+2.71%) As of 02/21/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cognition Therapeutics (NASDAQ:CGTX)CurrentInstitutional OwnershipPercentage43.35%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$7.27MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$2.84M Get CGTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cognition Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CGTX Institutional Buying and Selling by Quarter Cognition Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Two Sigma Investments LP53,691$38K0.0%+372.2%0.129% 2/14/2025 Voss Capital LP500,000$351K0.0%N/A1.203% 2/12/2025 Geode Capital Management LLC352,348$247K0.0%+8.9%0.848% 2/11/2025 Virtu Financial LLC80,180$56K0.0%+40.1%0.193% 2/10/2025 BIOS Capital Management LP6,000,000$4.21M4.5%N/A14.441% 2/7/2025 CM Management LLC200,000$140K0.1%-20.0%0.481% 2/3/2025 Sigma Planning Corp614,490$431K0.0%+211.6%1.479% 1/17/2025 SG Americas Securities LLC37,108$26K0.0%N/A0.089% 11/20/2024 Virtu Financial LLC57,231$27K0.0%N/A0.138% 11/4/2024 Sigma Planning Corp197,190$92K0.0%+14.6%0.491% Get the Latest News and Ratings for CGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/12/2024 Mercer Global Advisors Inc. ADV95,951$159K0.0%+33.4%0.240% 8/9/2024 Renaissance Technologies LLC89,718$149K0.0%-42.4%0.224% 8/7/2024 AIGH Capital Management LLC300,766$499K0.2%-84.1%0.751% 8/2/2024 CM Management LLC200,000$332K0.3%+14.3%0.499% 7/16/2024 Bangor Savings Bank34,019$56K0.0%+41.6%0.085% 5/16/2024 Levin Capital Strategies L.P.30,000$55K0.0%N/A0.075% 5/16/2024 AWM Investment Company Inc.650,000$1.18M0.2%N/A1.623% 5/14/2024 Carlson Capital L P213,995$389K0.0%-10.1%0.534% 5/14/2024 CM Management LLC175,000$318K0.3%N/A0.437% 5/10/2024 Tocqueville Asset Management L.P.26,000$47K0.0%N/A0.065% 5/8/2024 Hohimer Wealth Management LLC225,000$410K0.1%N/A0.562% 3/5/2024 Twin Focus Capital Partners LLC93,372$173K0.0%N/A0.291% 2/8/2024 Texas Capital Bank Wealth Management Services Inc55,395$102K0.0%N/A0.172% 2/1/2024 Sigma Planning Corp28,550$53K0.0%N/A0.089% 10/23/2023Steward Financial Group LLC40,874$58K0.0%N/A0.135% 7/28/2023 Voss Capital LLC60,222$110K0.0%-62.4%0.206% 5/12/2023 Voss Capital LLC159,973$317K0.0%-4.2%0.546% 5/12/2023 FCA Corp TX51,471$102K0.0%N/A0.176% 2/16/2023 AIGH Capital Management LLC2,037,853$4.28M1.4%+155.3%7.030% 2/13/2023 Northeast Financial Consultants Inc24,500$51K0.0%N/A0.085% 2/13/2023 Voss Capital LLC166,903$350K0.1%-23.8%0.576% 2/13/2023Financial Partners Capital Management LLC14,228$30K0.0%N/A0.049% 2/7/2023 Commonwealth Equity Services LLC189,307$397K0.0%-13.6%0.653% 2/6/2023 Neumann Capital Management LLC33,382$70K0.0%N/A0.115% 1/31/2023 Kestra Advisory Services LLC50,618$106K0.0%+237.5%0.175% 1/20/2023 Diligent Investors LLC20,000$42K0.0%-34.5%0.069% 12/13/2022 Perigon Wealth Management LLC36,900$70K0.0%-70.0%0.127% 11/15/2022 Carlson Capital L P100,000$190K0.0%N/A0.440% 11/14/2022 Worth Venture Partners LLC200,188$380K0.2%-12.3%0.881% 11/10/2022 Rock Creek Group LP50,000$95K0.0%-37.3%0.220% Elon Social Security shock? (Ad)“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One Boston based think tank believes it could have drastic impacts on your money and life in America.Get the details here.11/2/2022 Voss Capital LLC219,100$416K0.1%-29.2%0.965% 11/1/2022 P.A.W. Capital Corp100,000$190K0.3%-25.9%0.440% 10/12/2022 Wealth Alliance Advisory Group LLC18,500$35K0.0%N/A0.081% 8/13/2022 Voss Capital LLC309,472$653K0.2%+1,070.5%1.363% 8/13/2022 Prosight Management LP120,198$254K0.2%-49.9%0.532% 8/11/2022 Perigon Wealth Management LLC122,846$259K0.0%N/A0.544% 8/8/2022 Rock Creek Group LP79,751$170K0.0%+201.6%0.353% 8/1/2022 Castle Wealth Management LLC43,380$92K0.1%N/A0.192% 7/19/2022 Commonwealth Equity Services LLC214,961$453K0.0%+1,447.6%0.951% 7/13/2022 P.A.W. Capital Corp135,000$285K0.4%+12.5%0.597% 5/17/2022 Prosight Management LP240,080$660K0.4%-20.5%1.062% 5/4/2022 Commonwealth Equity Services LLC13,890$38K0.0%N/A0.061% 4/26/2022 Diligent Investors LLC30,520$84K0.0%N/A0.135% 4/26/2022 Kestra Advisory Services LLC238,666$656K0.0%+150.9%1.057% 4/21/2022 P.A.W. Capital Corp120,000$330K0.3%+20.0%0.531% 4/14/2022 Bangor Savings Bank18,496$51K0.0%N/A0.082% 2/10/2022 B. Riley Financial Inc.30,904$195K0.0%N/A0.140% 2/10/2022 American Financial Group Inc.205,000$1.30M0.4%N/A0.930% 2/10/2022 AIGH Capital Management LLC25,496$161K0.0%N/A0.116% 2/10/2022 P.A.W. Capital Corp100,000$632K0.6%N/A0.454% (Data available from 1/1/2016 forward) CGTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGTX shares? During the previous two years, 22 institutional investors and hedge funds held shares of Cognition Therapeutics. The most heavily invested institutionals were BIOS Capital Management LP ($4.21M), AWM Investment Company Inc. ($1.18M), AIGH Capital Management LLC ($499K), Sigma Planning Corp ($431K), Hohimer Wealth Management LLC ($410K), Carlson Capital L P ($389K), and Voss Capital LP ($351K).Learn more on CGTX's institutional investors. What percentage of Cognition Therapeutics stock is owned by institutional investors? 43.35% of Cognition Therapeutics stock is owned by institutional investors. Learn more on CGTX's institutional investor holdings. Which institutional investors have been buying Cognition Therapeutics stock? Of the 18 institutional investors that purchased Cognition Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($6M), AWM Investment Company Inc. ($650K), Voss Capital LP ($500K), Sigma Planning Corp ($470.90K), Hohimer Wealth Management LLC ($225K), CM Management LLC ($200K), and Twin Focus Capital Partners LLC ($93.37K). How much institutional buying is happening at Cognition Therapeutics? Institutional investors have bought a total of 8,565,376 shares in the last 24 months. This purchase volume represents approximately $7.58M in transactions. Which Cognition Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cognition Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($1.60M), Voss Capital LLC ($106.68K), Renaissance Technologies LLC ($65.98K), CM Management LLC ($50K), and Carlson Capital L P ($24.01K). How much institutional selling is happening at Cognition Therapeutics? Institutional investors have sold a total of 1,843,175 shares in the last 24 months. This volume of shares sold represents approximately $3.03M in transactions. Related Companies Metagenomi Institutional Ownership Elutia Institutional Ownership Oramed Pharmaceuticals Institutional Ownership MediciNova Institutional Ownership Alpha Cognition Institutional Ownership Skye Bioscience Institutional Ownership Tenaya Therapeutics Institutional Ownership Cue Biopharma Institutional Ownership Vor Biopharma Institutional Ownership SELLAS Life Sciences Group Institutional Ownership This page (NASDAQ:CGTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cognition Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGTX Stock Alerts